4.7 Letter

Correspondence on 'Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study'

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population--based cohort study

Shahab Abtahi et al.

Summary: The simultaneous use of oral glucocorticoids (GCs) and proton pump inhibitors (PPIs) increases the risk of osteoporotic fractures in patients with rheumatoid arthritis (RA), whereas the risk is relatively lower when GCs or PPIs are used alone. Among patients using both oral GCs and PPIs, the risk of fractures does not increase with higher PPI daily dose or duration.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Article Rheumatology

Medications associated with fracture risk in patients with rheumatoid arthritis

Gulsen Ozen et al.

ANNALS OF THE RHEUMATIC DISEASES (2019)

Article Endocrinology & Metabolism

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

J. A. Kanis et al.

OSTEOPOROSIS INTERNATIONAL (2019)

Review Endocrinology & Metabolism

Efficacy of statins for osteoporosis: a systematic review and meta-analysis

T. An et al.

OSTEOPOROSIS INTERNATIONAL (2017)

Article Medicine, General & Internal

Statins and Physical Activity in Older Men The Osteoporotic Fractures in Men Study

David S. H. Lee et al.

JAMA INTERNAL MEDICINE (2014)